Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus.

Söderlund-Strand A, Carlson J, Dillner J.

J Clin Microbiol. 2009 Mar;47(3):541-6. doi: 10.1128/JCM.02007-08. Epub 2009 Jan 14.

2.

WHO meeting on the standardization of HPV assays and the role of the WHO HPV Laboratory Network in supporting vaccine introduction held on 24-25 January 2008, Geneva, Switzerland.

Ferguson M, Wilkinson DE, Zhou T.

Vaccine. 2009 Jan 14;27(3):337-47. doi: 10.1016/j.vaccine.2008.10.062. Epub 2008 Nov 11.

PMID:
19007840
3.

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older.

Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DA, Snijders PJ.

Int J Cancer. 2009 Feb 1;124(3):516-20. doi: 10.1002/ijc.24010.

4.

Comparison of the performance of different HPV genotyping methods for detecting genital HPV types.

Klug SJ, Molijn A, Schopp B, Holz B, Iftner A, Quint W, J F Snijders P, Petry KU, Krüger Kjaer S, Munk C, Iftner T.

J Med Virol. 2008 Jul;80(7):1264-74. doi: 10.1002/jmv.21191.

PMID:
18461626
5.

Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers.

Schmitt M, Dondog B, Waterboer T, Pawlita M.

J Clin Microbiol. 2008 Mar;46(3):1050-9. doi: 10.1128/JCM.02227-07. Epub 2008 Jan 16.

6.

Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system.

Stevens MP, Garland SM, Tabrizi SN.

J Virol Methods. 2008 Feb;147(2):290-6. Epub 2007 Nov 8.

PMID:
17996311
7.

Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test.

Coutlée F, Rouleau D, Ghattas G, Hankins C, Vézina S, Coté P, Macleod J, de Pokomandy A, Money D, Walmsley S, Voyer H, Brassard P, Franco E.

J Clin Microbiol. 2007 Nov;45(11):3821-3. Epub 2007 Sep 26.

8.

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM.

Int J Cancer. 2007 Aug 1;121(3):621-32.

9.

Development and evaluation of a colorimetric PCR system for the detection and typing of human papillomaviruses.

Chouhy D, Gil LB, Nocito AL, Wojdyla D, Ornella L, Cittadini J, Gardiol D, Giri AA.

Int J Mol Med. 2006 Nov;18(5):995-1003.

PMID:
17016633
10.

Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types.

Gheit T, Landi S, Gemignani F, Snijders PJ, Vaccarella S, Franceschi S, Canzian F, Tommasino M.

J Clin Microbiol. 2006 Jun;44(6):2025-31.

11.

Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology.

Snijders PJ, Hogewoning CJ, Hesselink AT, Berkhof J, Voorhorst FJ, Bleeker MC, Meijer CJ.

Int J Cancer. 2006 Sep 1;119(5):1102-7.

12.

Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.

Quint WG, Pagliusi SR, Lelie N, de Villiers EM, Wheeler CM; World Health Organization Human Papillomavirus DNA International Collaborative Study Group.

J Clin Microbiol. 2006 Feb;44(2):571-9.

13.

Bead-based multiplex genotyping of human papillomaviruses.

Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T.

J Clin Microbiol. 2006 Feb;44(2):504-12.

14.

Detection and typing of human papillomavirus by e6 nested multiplex PCR.

Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bültmann B.

J Clin Microbiol. 2004 Jul;42(7):3176-84.

15.

An international external quality assessment of nucleic acid amplification of herpes simplex virus.

Schloss L, van Loon AM, Cinque P, Cleator G, Echevarria JM, Falk KI, Klapper P, Schirm J, Vestergaard BF, Niesters H, Popow-Kraupp T, Quint W, Linde A.

J Clin Virol. 2003 Oct;28(2):175-85.

PMID:
12957188
16.

The causal relation between human papillomavirus and cervical cancer.

Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV.

J Clin Pathol. 2002 Apr;55(4):244-65. Review.

17.

GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.

van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ.

J Clin Microbiol. 2002 Mar;40(3):779-87.

18.

Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program.

Schuurman R, Brambilla D, de Groot T, Huang D, Land S, Bremer J, Benders I, Boucher CA; ENVA Working Group.

AIDS Res Hum Retroviruses. 2002 Mar 1;18(4):243-8.

PMID:
11860670
19.

European proficiency testing program for molecular detection and quantitation of hepatitis B virus DNA.

Valentine-Thon E, van Loon AM, Schirm J, Reid J, Klapper PE, Cleator GM.

J Clin Microbiol. 2001 Dec;39(12):4407-12.

20.

Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus.

Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, Lindeman J, ter Harmsel B, Burger M, Quint W.

J Clin Microbiol. 1999 Aug;37(8):2508-17.

Supplemental Content

Support Center